TrialClinical pharmacokinetics2024

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers.

Brit S Rohr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.